OSD and Injectable Oncology - Verna, Goa - Installation completed and under process validation
OSD - Skidel, Belarus Inaugurated on 7-Mar-19. Commercial Licence Obtained in Dec-2019
ONCO API, Goa - Building is ready, machine installations in progress
Face mask, Two Yard distance and hand wash is must
R&D and ADL centre has certified by DSIR, Govt. of India.
Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg And Favipiravir 200 mg/400mg/800mg Tablet.
Having corporate office in Mumbai-India, Moscow-Russia, Kiev-Ukraine, & Minsk-Belarus, Lok-Beta is able to expend its marketing operations in Asia Pacific, Latin America and Africa Market covering more than 23 countries.
Fight against Novel Coronavirus ( COVID-19)
LOPIRAVIR - 250 mg / 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Manufactured by J Duncan Healthcare Pvt. Ltd, Marketed by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.
TINAROVIR - 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Marketed and Manufactured by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.
The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness.
For details please visit Product menu
The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.